Working at Cancer Genetics | Glassdoor

Cancer Genetics Overview

Rutherford, NJ
201 to 500 employees
Company - Public (CGIX)
Biotech & Pharmaceuticals
$25 to $50 million (USD) per year
Cancer Genetics, Inc. (CGI) is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI has a global footprint with state-of-the-art facilities in the US (NJ, NC & CA), India ... Read more

Mission: Our Mission: Empowering personalized cancer treatment that will increase treatment efficacy, and reduce healthcare costs.

Our Values: Our core values are built around the respect of the patient and the desire to provide quality ... Read more

Company Updates

  • CGI Now Offers FDA-cleared Tissue of Origin® Test The Tissue of Origin test a microarray-based gene expression test that aids in identifying challenging tumors, including metastatic, poorly differentiated, and undifferentiated cancers.

  • Feb. 3 2016: FDA-Approved PD-L1 Testing Now Available: The FDA approved PD-L1 (IHC) 22C3 pharmDx companion diagnostic test for KEYTRUDA® (pembrolizumab)​ is now available at CGI to assess PD-L1 expression in Non-Small Cell Lung Cancer.

See AllSee All

Cancer Genetics – Why Work For Us?


An Emerging Leader in Cancer Diagnostics

Cancer Genetics, Inc. (CGI) is an emerging leader in the field of personalized medicine, offering diagnostic products and services that enable precision medicine in the field of oncology.

Products and services being developed at CGI are poised to transform cancer patient management, increase treatment efficacy, and reduce healthcare costs. CGI’s cutting-edge proprietary tests and state-of-the-art reference laboratory provide critical genomic information where patients and their physicians need it most – to diagnose, monitor and inform cancer treatment.

CGI is committed to maintaining the standard of clinical excellence through its investment in outstanding facilities and equipment. Our clinical reference laboratory is both CLIA-certified and CAP-accredited. In addition we have approvals and accreditations from the states of Florida, Maryland, New York, California, and New Jersey. Our clinical trial support services and global facilities help biotech and biopharma companies deliver more personalized treatments to market.

CGI is focused on delivering products and services that drive the highest levels of patient value. To achieve this, we have developed a corporate culture that inspires innovation, respects knowledge and fosters leadership. Our dedicated staff takes pride in our specialized laboratory services, superior turnaround time (TAT), enhanced reporting, EMR integration, and ongoing research and development for new tests. CGI’s full-service cancer genetic practice and path to innovation with research makes for optimal patient care management.

With locations in the US, India, and China, we are helping to empower personalized cancer treatment around the globe.


 

Our History

Cancer Genetics, Inc. was founded by world-renowned cytogeneticist Dr. R.S.K. Chaganti. Today, CGI’s scientific advisory board includes key thought leaders in the areas of hematological malignancies, solid tumor cancers, pharmacogenomics, and clinical trials administration. Built on a foundation of world-class scientific knowledge and IP in solid and blood-borne cancers, the company continues to develop strong research collaborations with major cancer centers and academic institutions.

In 2013, CGI launched a joint-venture with Mayo Clinic, Oncospire Genomics. Working to meet areas of critical need in oncology, Oncospire Genomics seeks to improve cancer care by discovering and commercializing diagnostic tests that leverage NGS technology.

In 2014, CGI acquired Gentris, LLC (based in Raleigh, NC) and Bioserve Biotechnologis Pvt. Ltd. (based in Hyderabad, India. Gentris | A CGI Company is a market leader in providing pharmacogenomics testing, genotyping, and biorepository services to the pharmaceutical and biotech industries. Gentris advances personalized medicine by partnering with pharmaceutical, academic, and technology leaders to effectively integrate pharmacogenomics into their drug development and clinical trial programs with the goals of delivering safer, more effective drugs to market more quickly, and improving patient care. Gentris’ clinical trials services, as well as their international services and Shanghi, China operations, have been integrated into CGI’s Select One® clinical trials offering, allowing CGI to provide the most robust and personalized clinical trial services available to our biotech and pharma customers.

Based in Hyderabad, India, BioServe India (now Cancer Genetics India) was the first company to provide DNA synthesis, DNA sequencing, and related services in India. Cancer Genetics India brings Indian cientists, pharmaceutical companies, and research institutes a ‘Biomaterial to Data’ model that offers a full suite of molecular services and research tools to accelerate breakthroughs in genetics, drug discovery, biomarker research, and molecular diagnostics. CG-India’s customers include nearly every Indian Council of Medical Research (ICMR) and Council for Scientific and Industrial Research (CSIR) institute and several major pharmaceutical and biotechnology companies, as well as top industry and academic researchers.

CGI is an expanding personalized medicine company, focused on cancer treatment through molecular diagnostics, genomics research, and comprehensive and integrated laboratory testing services. We are dedicated to the mission of providing genomic solutions to the clinical, biopharmaceutical, and research communities.

Our state-of-the art laboratory, centrally located in Rutherford, NJ, and just minutes from NYC.

CGI offers comprehensive benefits, competitive compensation and an innovative environment that encourages active learning and scientific inquiry. The company has been ranked amongst the 20 best places to work in the industry by the The Scientist Magazine.

Cancer Genetics Reviews

2.4
StarStarStarStarStar
Rating TrendsRating Trends
Recommend to a friend
Approve of CEO
(no image)
Panna Sharma
21 Ratings
  • "Leading Edge Technology"

    StarStarStarStarStar
    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee
    Neutral Outlook

    I have been working at Cancer Genetics full-time (More than a year)

    Pros

    Plenty of opportunities to influence process changes.

    Cons

    Technology initiatives moving faster than infrastructure can handle.

    Advice to Management

    Continue to communicate changes and vision to the company.

See All 34 Reviews

Cancer Genetics Photos

Cancer Genetics photo of: Laboratory
Cancer Genetics photo of: CGI Celebrates LabWeek 2016 with a little Grillin' & Chillin'
Cancer Genetics photo of: CGI Recognizes Breast Cancer Awareness Month
Cancer Genetics photo of: CGI Recognizes World Cancer Day - We Can. I Can.
Cancer Genetics photo of: Laboratory
Cancer Genetics photo of: CGI Company Outing to Medieval Times
See All PhotosSee All

Cancer Genetics Interviews

Experience

Experience
37%
37%
25%

Getting an Interview

Getting an Interview
25%
25%
25%
12
12

Difficulty

2.9
Average

Difficulty

Hard
Average
Easy
  1.  

    Intern Interview

    Anonymous Interview Candidate
    Declined Offer
    Negative Experience
    Average Interview

    Application

    I applied through a recruiter. The process took 2 weeks. I interviewed at Cancer Genetics.

    Interview

    Representatives of the company's management conducting the interview were polite, but overall, presented the process as divided & disorganized. Each person in turn asked the same question just rehashed in a different form.

    Interview Questions

    • If offered this position within the company, how do you see yourself contributing to the company's future?   Answer Question
See All 9 Interviews

Cancer Genetics Awards & Accolades

  • NJBiz Healthcare Heros Finalists, NJBiz, 2016
  • NJBiz CFO of the Year, NJBiz, 2015
  • Deloitte Technology Fast 500, Deloitte’s Technology Fast 50, 2015
  • Deloitte’s Technology Fast 500™, Deloitte's Technology Fast 500™, 2014
  • New Jersey Tech Council(INDUSTRY AWARDS), NJTC, 2014
See More

Work at Cancer Genetics? Share Your Experiences

Cancer Genetics
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or